More than 200 genes with novel and known roles in glioblastoma - the most aggressive type of brain cancer - offer promising new drug targets. Researchers engineered a new mouse model to show for the first time how a mutation in the well-known cancer gene, EGFR initiates glioblastoma, and works with a selection from more than 200 other genes to drive the cancer.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/07/200729210506.htm
No comments:
Post a Comment